Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
Earnings call · FY2025 Q3
Executive readout · one minute
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
Management tone
Positive
Net tone +35 · low hedging
Research coverage
4 live sources
Switch sources without leaving this page or losing your listening position.
Open the source you need; every reader stays inside this workspace.
How the reported period landed and where the business moved.
Listen and read together
The spoken word highlights as audio plays. Select any word to seek to that moment.
Good day, and welcome to the FITUS 3rd Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then 1 on a touch-tone phone. To withdraw your question, please press star then 2. Please note this event is being recorded. I would now like to turn the conference over to Jody Berfening. Please go ahead.
Thank you, Bailey, and good morning, everyone. And thank you for joining us for FITUS Investment Corporation's third quarter 2025 earnings conference call. With me this morning are Ed Ross, FITUS Investment Corporation's Chairman and Chief Executive Officer, and Shelby Sherrod, Chief Financial Officer. Linus Investment Corporation issued a press release yesterday afternoon with the details of the company's quarterly financial results. A copy of the press release is available on the Investor Relations page of the company's website at fdus.com. I'd also like to call your attention to the customary Safe Harbor disclosure regarding forward-looking information included on today's call. Conference call today will contain forward-looking statements, including statements regarding the goals, strategies, beliefs, future potential, operating results, and cash flows of Finest Investment Corporation. Although management believes these statements are reasonable, based on estimates, assumptions, and projections as of today, November 7, 2025, these statements are not guarantees of future performance. Time-sensitive information may no longer be accurate at the time of any telephonic or webcast replay. Actual results may differ materially as a result of risks, uncertainties, and other factors, including, but not limited to, the factors set forth in the company's filings with the Securities and Exchange Commission. Vitus undertakes no obligation to update or revise any of these forward-looking statements. With that, I would now like to turn the call over
to Ed. Good morning, Ed. Good morning, Jody, and good morning, everyone, and our portfolio at quarter end, and then share with you our outlook for the last quarter of 2025. Shelby will cover the third quarter financial results and our liquidity position. We've completed our prepared remarks. We'll be happy to take your questions. We continue to perform well, and we extended our track record of generating adjusted NII well in excess of the base dividend. Overall, the portfolio remains healthy from a credit quality perspective, reflecting our strategy of investing in high-quality, lower-middle market companies with resilient business models that generate recurring revenue and cash flow and have attractive prospects for growth. Our portfolio also remains well-diversified by industry and structured to produce both high levels of recurring income and capital gains from monetizing equity investments. In terms of market conditions, M&A activity did pick up in the third quarter relative to the first half of the year, as expected. Although deal closings were back-end loaded and some deals were pushed into October, we continued to build our portfolio primarily by supporting our portfolio companies with growth capital, leveraging our long-standing relationships with deal sponsors. The share basis adjusted NII was $0.50 compared to $0.61 for Q3 2024, covering our base dividend of $0.43 with ample cushion. Total dividends paid for the quarter amounted to $0.57 per share, including a supplemental dividend of $0.14 per share. For the fourth quarter of 2025, the Board of Directors declared a total dividend of $0.50 per share, which consists of a base dividend of $0.43 per share and a supplemental dividend of $0.07 per share, equal to 100% of the surplus in adjusted NII over the base dividend from the prior quarter, which will be payable on December 29th, 2025, to stockholders of record as of December 19th, 2025. Net asset value grew 2.7% to $711 million at quarter end, compared to $692.3 million as of June 30, 2025, reflecting modest portfolio appreciation and accretive share issuances under the ATM program. On a per-share basis, net asset value was $19.56 per share as of September 30, 2025, compared to $19.57 per share as of June 30, 2025. Originations consisted of $69.7 million in first lien securities and $4.7 million in equity investments for a total of $74.5 million for the third quarter. Investments were heavily weighted toward add-on investments, primarily in support of M&A transactions. We also invested $12.8 million in one new portfolio company. Subsequent to quarter end, we have invested an additional $40.2 million in two new portfolio companies, plus numerous add-on investments in existing companies from repayments and realizations totaled $36.7 million for the third quarter, resulting from a mix of M&A and refinancing activity. With net originations of $37.8 million, our portfolio grew to $1.2 billion on a fair value basis as of September 30th, 2025, equal to 102% of cost. First lien investments comprised 82% of our debt portfolio as the migration of our debt portfolio toward First Lean Securities continued, and our equity portfolio stood at $143.4 million, or 12% of the total portfolio at quarter end. Credit quality remained sound, with companies on nonaccrual unchanged at less than 1% of the total portfolio on a fair value basis and 2.8% of the total portfolio on a cost As we enter the home stretch for 2025, market activity is shaping up to be relatively decent in the fourth quarter, and we are working hard to convert opportunities from our pipeline of potential investments in both new and existing portfolio companies while continuing to add to our overall investment pipeline. As Shelby will detail, we have enhanced our flexibility from a capitalization and liquidity perspective, continuing to position FITUS for the future as we execute our proven investment strategy, methodically building the portfolio and growing that asset value over time. In doing so, we will stay focused on our goals of preserving capital and generating attractive risk-adjusted returns for our shareholders. Now I'll turn the call over to Shelby to provide some details on our financial and operating results. Shelby?
Thank you, Ed, and good morning, everyone. I'll review our third quarter results in more detail and close with comments on our liquidity position. Please note I will be providing comparative commentary versus the prior quarter, Q2, 2025. Total investment income was $37.3 million for the three months ended September 30th, a $2.7 million decrease from Q2, driven by a $0.7 million decrease in interest income primarily due to approximately 0.6 million of accelerated income from unamortized fees on debt repayments in Q2. A 2.6 million decrease in fee income given a 1.3 million decrease in prepayment fees, a 0.8 million decrease in origination fees, and a 0.5 million decrease in amendment and management fees. Dividend income from equity investments increased by 0.4 million in Q3. Total expenses including income tax provision were 19.9 million for the third quarter. A $1.5 million decrease over Q2, driven primarily by a $1 million decrease in capital gains incentive accrual, a $0.4 million decrease in base management and income incentive fees, a $0.3 million decrease in professional and other G&A fees, primarily related to proxy solicitation expenses for the 2025 annual shareholder meeting held in Q2, partially offset by increased legal fees in Q3. A $0.3 million increase in taxes related to distributions from our equity investments in MedShare and Holdings. Net investment in Cummer NII for the three months ended September 30th was $0.49 per share in Q3 versus $0.53 per share in Q2. Adjusted NII, which excludes any capital gains in Senate fee accruals or reversals attributable to realized and unrealized gains and losses on investments, was $0.50 per share in Q3 versus $0.57 per share in Q2. We ended Q3 with $543.8 million of debt outstanding, comprised of $191 million of SBA debentures, $325 million of unsecured notes, $15 million outstanding on the line of credit, and $12.8 million of secured borrowings. Our net debt-to-equity ratio as of September 30th was 0.7 times. Our statutory leverage, excluding exempt SBA debentures, was 0.5 times. The weighted average interest rate on our outstanding debt was 4.9% as of September 30th. Turning now to portfolio statistics, as of September 30th, our total investment portfolio had a fair value of $1.2 billion. Our average portfolio company investment on a cost basis was $12.6 million, which excludes investments in six portfolio companies that sold their operations and are in the process of winding down. We have equity investments in approximately 87.8% of our portfolio companies with an average fully diluted equity ownership of 2%. Weighted average effective yield on debt investments was 13% as of September 30th versus 13.1% at the end of Q2. The weighted average yield is computed using effective interest rates for debt investments at cost, including the accretion of original issue discount and loan origination fees, but excluding investments on non-accrual, if any. Now I'd like to briefly discuss our available liquidity. Subsequent to quarter end, we completed a $100 million debt add-on to our 6.75% notes due in March 2030. The net proceeds were used to fully redeem the 4.75% notes due in January 2026. In addition, we refinanced our line of credit, which included an upsize to $175 million of availability and a new maturity date of October 16, 2030. As of September 30th, our liquidity and capital resources included cash of $62.3 million, $125 million of availability on our line of credit, and $16.5 million of available SBA debentures, resulting in total liquidity of approximately $203.8 million. Taking into account our subsequent events, our liquidity remains approximately $204 million. Now I will turn the call back to Ed for concluding comments.
Thanks, Shelby, for your dedication and hard work and our shareholders for their continued
We will now begin the question and answer session. To ask a question, you may press star then 1 on your touchtone phone. If you are using the speakerphone, please pick up your handset before pressing the keys. If at any time your question has been addressed and you would like to withdraw the question, please press star then 2. At this time, we will pause momentarily to assemble our roster. Our first question comes from Robert Dodd with Raymond James. Please go ahead.
Hi, everybody. Congratulations on another really good quarter. I've got to ask about your comment about market activity outlook for 4Q. I think you called it, it looks relatively decent. I think that's the first time you've used those words. I mean, the earlier comments, I mean, deal activity picking up, you've already done $40 million in October. I mean, can you give us any more thought? Do you think it's going to slow any, or do you think it's just going to continue to ramp? And is there, given some Q3 of the Q3 ramps into October, like you said, is there a risk that there's a lot of activity, but some of it ends up in January?
A couple of deals fell apart at the end, things like that, which accounted for a little slower quarter than we were expecting. But from an investment perspective, but having said that, deal flow was pretty good. And deal flow continues to be pretty good as we sit here today and this week. And so I think that bodes well for the it's it's healthy. And so that's a you know, that's a good thing. So what does that mean for us? I think origination will be pronged, both from an incremental new investment perspective and from add-on investment perspective. And we've also had, you know, several add-on investments, you know, so far this quarter as well. So it's a busy quarter at the moment, and our expectation as we sit here today is for that kind of trend to continue. Hopefully that's helpful.
Yeah, that is very helpful. Thank you. And just kind of following on from that, I mean, how are you seeing deal terms and pricing stack up? Obviously, the terms are good enough or you wouldn't be doing them. But, you know, has there been any evolution in terms of how structures are being proposed as you go into this builder pipeline?
A pricing standpoint, obviously we're pricing risk. And so some deals may be in the spreads in the low fives and some may be actually in the sixes. So you can't, you know, stabilize, which is a good thing. And I think one of the other positives of the lower middle market is structures. I mean, we have two covenants in almost all of our deals, typically a leverage covenant and a fixed charge covenant. And so the structures are the same. I think leverage levels have stayed pretty close to the same. So there haven't been increased risks, if you will, that we're taking to generate the yields that we're getting. So I think all that's positive and gives us the ability to generate
you know, attractive risk-adjusted returns. Got it. Thank you. That's it for me. Congrats
again on the quarter. Thank you. Good talking to you, Robert.
Our next question comes from Mickey Schleen with Clear Street. Please go ahead.
Yes. Good morning, everyone. Ed, this quarter we've seen in the space more impact from tariff policy, particularly in relation to China. You know, we've been talking about this for a while, but these things, you know, develop slowly. Can you remind us, you know, do you have companies that are, you know, relatively exposed to importation from China, and is pressure developing
on those companies? Good question, Mickey. I think it's quite limited. It's various actions taken by these portfolio companies, whether it's price increases, whether it's negotiations, what have
Well, that's good to hear. And a follow-up question. It may be transient, but the government shutdown is now longer than we would like. Is that going to impact any of your portfolio companies? I know it may be a short-term sort of event, but it could take a while to get things back to normal as the government reopens. Okay, that's good to hear as well. Those are all my questions this morning.
Good talking with you, Ed. Likewise. Nice talking to you, Mickey. Thank you.
Again, if you have a question, please press star, then 1. This concludes our question and answer session. I would like to turn the conference back over to Ed Ross for any closing remarks.
2026. Have a great day and a great weekend.
The conference is now concluded. Thank you for attending today's presentation. You may now disconnect.
SEC filing · Item 2.02
Filed Nov 6, 2025 · complete as-filed document
SEC periodic report
Filed Nov 6, 2025 · complete as-filed document